Dziki cigym badaniom i nowym odkryciom, semaglutyd moe doczeka si jeszcze szerszego zastosowania, co przyniesie nadziej wielu pacjentom
Ive noticed real benefits from the IV vitamin drips and Red light therapy
Join Michelle at our Clinical Evidence Course Auckland | 23 May 2026 | NZD $1,025 +GST #ClinicalEvidence #MedicalEducation #MedicalAffairs #MarketAccess #LifeSciences #HealthTech #MedTech #ProfessionalDevelopment To view or add a comment, sign in Day - 7 Phase I Clinical Trial Definition First-in-human study Also called: Human Pharmacology Phase MTD (Maximum Tolerable Dose) Phase Study Design Can be: Single-centre / Multi-centre Single-national / Multi-national Subjects Conducted on healthy volunteers (stable physiology) Sample Size 20 100 subjects Objectives 1 Primary Endpoint To determine MTD (Maximum Tolerable Dose) Highest dose tolerated without serious adverse events (SAEs) 2 Secondary Endpoint Study: Pharmacokinetics (PK) Pharmacodynamics (PD) MTD (Maximum Tolerable Dose) Definition Maximum dose of drug that is well tolerated without significant side effects Determination Methods SAD (Single Ascending Dose) MAD (Multiple Ascending Dose) Important Conditions Conducted in in-patient setting Subjects monitored 247 for safety Observe for adverse events (AEs) To view or add a comment, sign in Excited to announce our latest publication in Bentham Science - Medicinal Chemistry "Identification of Novel and Selective COX-2 Inhibitors: Comprehensive In-Silico Investigations" Chronic inflammation underlies some of the most debilitating conditions we face today including arthritis, cancer, cardiovascular disease
Curcumin also reduces chronic inflammation at the molecular level by downregulating inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2)
Oral glutathione at 250 mg per day, in both reduced and oxidized forms, effectively influences skin properties
Works on deeper marks too My pigmentation used to make my skin look uneven in photos
.png)
